Skip to main content
Medical information Clinical review pending

Infection Testing

Diphtheria Pertussis Tetanus Antibody Panel IgG Test

Assess your immunity levels against Diphtheria, Pertussis (Whooping Cough), and Tetanus with this IgG antibody panel test. Understand your protection status and guide vaccination decisions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
4 mL (2 mL minimum) serum collected in an SST tube.
Results
Results are typically available the next day if the sample is submitted by Tuesday at 6 PM. Confirm with the laboratory before booking.
Preparation
No specific preparation is required for this test. However, please inform the laboratory if you are currently taking any medications.
Test priceKSh 17,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Diphtheria Pertussis Tetanus Antibody Panel IgG Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Assessing immunity before vaccination or booster doses.
  • ✓Evaluating immune response after vaccination.
  • ✓Individuals with symptoms suggestive of Diphtheria, Pertussis, or Tetanus.
  • ✓People with compromised immune systems.
  • ✓Healthcare workers or individuals in high-risk environments.
  • ✓Confirming susceptibility in outbreak investigations.
02

In plain language

What this test helps you understand

This test helps determine if an individual has sufficient antibodies to protect against Diphtheria, Pertussis, and Tetanus, aiding in vaccination decisions and assessing immune status.
The Diphtheria Pertussis Tetanus Antibody Panel IgG Test is a diagnostic tool used to evaluate your body's immune response to Diphtheria, Pertussis (Whooping Cough), and Tetanus. These are serious infections that can cause significant health problems, particularly in children and individuals with weakened immune systems. This test measures the concentration of specific IgG antibodies in your blood, which are indicators of past exposure or vaccination-induced immunity. Understanding your immunity status is crucial for preventive healthcare and ensuring adequate protection against these diseases. This test provides valuable information for healthcare providers to make informed decisions regarding vaccination schedules and potential treatment needs.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific preparation is required for this test. However, please inform the laboratory if you are currently taking any medications.
Sample4 mL (2 mL minimum) serum collected in an SST tube.
MethodologyImmunoassay (e.g., ELISA or similar method) to detect and quantify IgG antibodies against Diphtheria, Pertussis, and Tetanus antigens.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Antibody levels may vary based on time since last vaccination or infection. Results should be interpreted in the context of the patient's vaccination history and clinical presentation. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test measures the levels of IgG antibodies in your blood, indicating your immune protection against Diphtheria, Pertussis (Whooping Cough), and Tetanus.
Individuals unsure of their vaccination status, those due for boosters, people with symptoms, or those with weakened immune systems may benefit from this test.
A blood sample is required for this test. A healthcare professional will draw blood from your arm.
Results are typically available the next day if the sample is submitted by Tuesday at 6 PM. Confirm with the laboratory before booking.
Your doctor will interpret the results based on the antibody levels detected and your personal health history to determine your immunity status.
No specific preparation is usually required, but inform the lab about any medications you are taking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp